pteridines and hmn-214

pteridines has been researched along with hmn-214 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Schöffski, P	1
Christensen, MD; Eaton, S; Elmer, JJ; Gonzalez-Malerva, L; LaBaer, J; Rege, K	1

Reviews

1 review(s) available for pteridines and hmn-214

Article	Year
Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. The oncologist, 2009, Volume: 14, Issue:6 Topics: Aniline Compounds; Animals; Cell Cycle Proteins; Clinical Trials as Topic; Cyclic N-Oxides; Drug Evaluation, Preclinical; Glycine; Humans; Neoplasms; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Pyridines; Sulfonamides; Sulfones; Thiazolidines	2009

Article

Year

Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology.

The oncologist, 2009, Volume: 14, Issue:6

Topics: Aniline Compounds; Animals; Cell Cycle Proteins; Clinical Trials as Topic; Cyclic N-Oxides; Drug Evaluation, Preclinical; Glycine; Humans; Neoplasms; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Pyridines; Sulfonamides; Sulfones; Thiazolidines

2009

Other Studies

1 other study(ies) available for pteridines and hmn-214

Article	Year
Kinome-level screening identifies inhibition of polo-like kinase-1 (PLK1) as a target for enhancing non-viral transgene expression. Journal of controlled release : official journal of the Controlled Release Society, 2015, Apr-28, Volume: 204 Topics: Cell Culture Techniques; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Cyclic N-Oxides; Dose-Response Relationship, Drug; Drug Carriers; Gene Silencing; Gene Transfer Techniques; Green Fluorescent Proteins; Humans; Luciferases; Male; Plasmids; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Pyridines; Small Molecule Libraries; Sulfonamides; Transgenes	2015

Article

Year

Kinome-level screening identifies inhibition of polo-like kinase-1 (PLK1) as a target for enhancing non-viral transgene expression.

Journal of controlled release : official journal of the Controlled Release Society, 2015, Apr-28, Volume: 204

Topics: Cell Culture Techniques; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Cyclic N-Oxides; Dose-Response Relationship, Drug; Drug Carriers; Gene Silencing; Gene Transfer Techniques; Green Fluorescent Proteins; Humans; Luciferases; Male; Plasmids; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Pyridines; Small Molecule Libraries; Sulfonamides; Transgenes

2015